nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP1A2—Carmustine—lymphatic system cancer	0.112	0.147	CbGbCtD
Methadone—CYP3A5—Teniposide—lymphatic system cancer	0.101	0.132	CbGbCtD
Methadone—CYP2C19—Teniposide—lymphatic system cancer	0.0815	0.107	CbGbCtD
Methadone—CYP2C9—Teniposide—lymphatic system cancer	0.0678	0.0888	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0648	0.0849	CbGbCtD
Methadone—CYP3A7—Vincristine—lymphatic system cancer	0.0648	0.0849	CbGbCtD
Methadone—CYP3A5—Vincristine—lymphatic system cancer	0.0486	0.0637	CbGbCtD
Methadone—ABCB1—Mitoxantrone—lymphatic system cancer	0.046	0.0603	CbGbCtD
Methadone—CYP3A4—Cytarabine—lymphatic system cancer	0.04	0.0524	CbGbCtD
Methadone—CYP3A4—Teniposide—lymphatic system cancer	0.0394	0.0516	CbGbCtD
Methadone—ABCB1—Vincristine—lymphatic system cancer	0.0316	0.0415	CbGbCtD
Methadone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0276	0.0361	CbGbCtD
Methadone—ABCB1—Methotrexate—lymphatic system cancer	0.0192	0.0251	CbGbCtD
Methadone—CYP3A4—Vincristine—lymphatic system cancer	0.019	0.0248	CbGbCtD
Methadone—Hypotensive—Teniposide—lymphatic system cancer	0.00899	0.0379	CcSEcCtD
Methadone—Osteoporosis—Fludarabine—lymphatic system cancer	0.00514	0.0217	CcSEcCtD
Methadone—Amenorrhoea—Mechlorethamine—lymphatic system cancer	0.00506	0.0214	CcSEcCtD
Methadone—Intracranial pressure increased—Carmustine—lymphatic system cancer	0.00442	0.0186	CcSEcCtD
Methadone—Cardiomyopathy—Mitoxantrone—lymphatic system cancer	0.00335	0.0141	CcSEcCtD
Methadone—Hypomagnesaemia—Bleomycin—lymphatic system cancer	0.00333	0.014	CcSEcCtD
Methadone—Phlebitis—Teniposide—lymphatic system cancer	0.00276	0.0117	CcSEcCtD
Methadone—Abdominal cramps—Vincristine—lymphatic system cancer	0.00261	0.011	CcSEcCtD
Methadone—Phlebitis—Fludarabine—lymphatic system cancer	0.00243	0.0103	CcSEcCtD
Methadone—Visual disturbance—Fludarabine—lymphatic system cancer	0.00221	0.00932	CcSEcCtD
Methadone—Cardiac failure—Fludarabine—lymphatic system cancer	0.00214	0.00905	CcSEcCtD
Methadone—Drug interaction—Carmustine—lymphatic system cancer	0.00199	0.0084	CcSEcCtD
Methadone—Amenorrhoea—Mitoxantrone—lymphatic system cancer	0.00195	0.00824	CcSEcCtD
Methadone—Drug interaction—Vincristine—lymphatic system cancer	0.0019	0.00801	CcSEcCtD
Methadone—Phlebitis—Bleomycin—lymphatic system cancer	0.00178	0.00752	CcSEcCtD
Methadone—Sweating increased—Fludarabine—lymphatic system cancer	0.00176	0.00744	CcSEcCtD
Methadone—Sweating—Teniposide—lymphatic system cancer	0.00176	0.00742	CcSEcCtD
Methadone—Vertigo—Mechlorethamine—lymphatic system cancer	0.00175	0.00738	CcSEcCtD
Methadone—Disorientation—Bleomycin—lymphatic system cancer	0.00171	0.00724	CcSEcCtD
Methadone—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00159	0.0067	CcSEcCtD
Methadone—Phlebitis—Carmustine—lymphatic system cancer	0.00155	0.00656	CcSEcCtD
Methadone—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00155	0.00656	CcSEcCtD
Methadone—Flushing—Teniposide—lymphatic system cancer	0.00153	0.00645	CcSEcCtD
Methadone—Osteoporosis—Methotrexate—lymphatic system cancer	0.00152	0.00643	CcSEcCtD
Methadone—Swelling—Carmustine—lymphatic system cancer	0.00152	0.00641	CcSEcCtD
Methadone—Anorexia—Mechlorethamine—lymphatic system cancer	0.00151	0.00639	CcSEcCtD
Methadone—Chills—Teniposide—lymphatic system cancer	0.00148	0.00624	CcSEcCtD
Methadone—Arrhythmia—Teniposide—lymphatic system cancer	0.00147	0.00621	CcSEcCtD
Methadone—Fracture—Methotrexate—lymphatic system cancer	0.00147	0.00621	CcSEcCtD
Methadone—Multiple fractures—Methotrexate—lymphatic system cancer	0.00147	0.00621	CcSEcCtD
Methadone—Phlebitis—Mitoxantrone—lymphatic system cancer	0.00144	0.0061	CcSEcCtD
Methadone—Swelling—Mitoxantrone—lymphatic system cancer	0.00141	0.00596	CcSEcCtD
Methadone—Visual impairment—Fludarabine—lymphatic system cancer	0.00139	0.00589	CcSEcCtD
Methadone—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00138	0.00582	CcSEcCtD
Methadone—Agitation—Teniposide—lymphatic system cancer	0.00132	0.00556	CcSEcCtD
Methadone—Chills—Fludarabine—lymphatic system cancer	0.0013	0.00548	CcSEcCtD
Methadone—Arrhythmia—Fludarabine—lymphatic system cancer	0.00129	0.00546	CcSEcCtD
Methadone—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00128	0.00539	CcSEcCtD
Methadone—Hypokalaemia—Carmustine—lymphatic system cancer	0.00122	0.00514	CcSEcCtD
Methadone—Cardiac arrest—Vincristine—lymphatic system cancer	0.00122	0.00513	CcSEcCtD
Methadone—Urinary retention—Vincristine—lymphatic system cancer	0.00122	0.00513	CcSEcCtD
Methadone—Lung disorder—Methotrexate—lymphatic system cancer	0.00121	0.0051	CcSEcCtD
Methadone—Weight decreased—Bleomycin—lymphatic system cancer	0.0012	0.00506	CcSEcCtD
Methadone—Confusional state—Teniposide—lymphatic system cancer	0.00118	0.00498	CcSEcCtD
Methadone—Oedema—Teniposide—lymphatic system cancer	0.00117	0.00494	CcSEcCtD
Methadone—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00117	0.00494	CcSEcCtD
Methadone—Agitation—Fludarabine—lymphatic system cancer	0.00116	0.00489	CcSEcCtD
Methadone—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00115	0.00484	CcSEcCtD
Methadone—Tachycardia—Teniposide—lymphatic system cancer	0.00114	0.00482	CcSEcCtD
Methadone—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00113	0.00478	CcSEcCtD
Methadone—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00113	0.00478	CcSEcCtD
Methadone—Pruritus—Mechlorethamine—lymphatic system cancer	0.00112	0.00474	CcSEcCtD
Methadone—Anorexia—Teniposide—lymphatic system cancer	0.00112	0.00471	CcSEcCtD
Methadone—Hypotension—Teniposide—lymphatic system cancer	0.00109	0.00462	CcSEcCtD
Methadone—Convulsion—Fludarabine—lymphatic system cancer	0.00109	0.00461	CcSEcCtD
Methadone—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00109	0.00458	CcSEcCtD
Methadone—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00105	0.00442	CcSEcCtD
Methadone—Confusional state—Fludarabine—lymphatic system cancer	0.00104	0.00438	CcSEcCtD
Methadone—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00103	0.00434	CcSEcCtD
Methadone—Oedema—Fludarabine—lymphatic system cancer	0.00103	0.00434	CcSEcCtD
Methadone—Decreased appetite—Teniposide—lymphatic system cancer	0.00102	0.00429	CcSEcCtD
Methadone—Vomiting—Mechlorethamine—lymphatic system cancer	0.00101	0.00426	CcSEcCtD
Methadone—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00101	0.00425	CcSEcCtD
Methadone—Rash—Mechlorethamine—lymphatic system cancer	0.001	0.00422	CcSEcCtD
Methadone—Dermatitis—Mechlorethamine—lymphatic system cancer	0.001	0.00422	CcSEcCtD
Methadone—Weight decreased—Vincristine—lymphatic system cancer	0.000999	0.00422	CcSEcCtD
Methadone—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000994	0.0042	CcSEcCtD
Methadone—Flushing—Bleomycin—lymphatic system cancer	0.000985	0.00416	CcSEcCtD
Methadone—Anorexia—Fludarabine—lymphatic system cancer	0.00098	0.00414	CcSEcCtD
Methadone—Weight increased—Mitoxantrone—lymphatic system cancer	0.000979	0.00413	CcSEcCtD
Methadone—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000973	0.00411	CcSEcCtD
Methadone—Feeling abnormal—Teniposide—lymphatic system cancer	0.000964	0.00407	CcSEcCtD
Methadone—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000959	0.00405	CcSEcCtD
Methadone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000957	0.00404	CcSEcCtD
Methadone—Chills—Bleomycin—lymphatic system cancer	0.000952	0.00402	CcSEcCtD
Methadone—Sweating—Vincristine—lymphatic system cancer	0.000944	0.00399	CcSEcCtD
Methadone—Nausea—Mechlorethamine—lymphatic system cancer	0.000943	0.00398	CcSEcCtD
Methadone—Urticaria—Teniposide—lymphatic system cancer	0.000929	0.00392	CcSEcCtD
Methadone—Glossitis—Methotrexate—lymphatic system cancer	0.000927	0.00391	CcSEcCtD
Methadone—Body temperature increased—Teniposide—lymphatic system cancer	0.000925	0.0039	CcSEcCtD
Methadone—Abdominal pain—Teniposide—lymphatic system cancer	0.000925	0.0039	CcSEcCtD
Methadone—Erythema—Bleomycin—lymphatic system cancer	0.000924	0.0039	CcSEcCtD
Methadone—Hallucination—Carmustine—lymphatic system cancer	0.000922	0.00389	CcSEcCtD
Methadone—Sweating—Mitoxantrone—lymphatic system cancer	0.00092	0.00388	CcSEcCtD
Methadone—Decreased appetite—Fludarabine—lymphatic system cancer	0.000894	0.00377	CcSEcCtD
Methadone—Visual impairment—Carmustine—lymphatic system cancer	0.000893	0.00377	CcSEcCtD
Methadone—Hallucination—Vincristine—lymphatic system cancer	0.00088	0.00371	CcSEcCtD
Methadone—Pain—Fludarabine—lymphatic system cancer	0.000879	0.00371	CcSEcCtD
Methadone—Constipation—Fludarabine—lymphatic system cancer	0.000879	0.00371	CcSEcCtD
Methadone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000877	0.0037	CcSEcCtD
Methadone—Hypersensitivity—Teniposide—lymphatic system cancer	0.000862	0.00364	CcSEcCtD
Methadone—Flushing—Carmustine—lymphatic system cancer	0.00086	0.00363	CcSEcCtD
Methadone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000847	0.00358	CcSEcCtD
Methadone—Asthenia—Teniposide—lymphatic system cancer	0.000839	0.00354	CcSEcCtD
Methadone—Pruritus—Teniposide—lymphatic system cancer	0.000828	0.00349	CcSEcCtD
Methadone—Arrhythmia—Carmustine—lymphatic system cancer	0.000827	0.00349	CcSEcCtD
Methadone—Body temperature increased—Fludarabine—lymphatic system cancer	0.000813	0.00343	CcSEcCtD
Methadone—Erythema—Carmustine—lymphatic system cancer	0.000806	0.0034	CcSEcCtD
Methadone—Diarrhoea—Teniposide—lymphatic system cancer	0.0008	0.00338	CcSEcCtD
Methadone—Chills—Mitoxantrone—lymphatic system cancer	0.000773	0.00326	CcSEcCtD
Methadone—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000769	0.00325	CcSEcCtD
Methadone—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00076	0.00321	CcSEcCtD
Methadone—Confusional state—Bleomycin—lymphatic system cancer	0.00076	0.00321	CcSEcCtD
Methadone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000758	0.0032	CcSEcCtD
Methadone—Tremor—Carmustine—lymphatic system cancer	0.000755	0.00319	CcSEcCtD
Methadone—Oedema—Bleomycin—lymphatic system cancer	0.000754	0.00318	CcSEcCtD
Methadone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000754	0.00318	CcSEcCtD
Methadone—Erythema—Mitoxantrone—lymphatic system cancer	0.00075	0.00316	CcSEcCtD
Methadone—Vomiting—Teniposide—lymphatic system cancer	0.000744	0.00314	CcSEcCtD
Methadone—Agitation—Carmustine—lymphatic system cancer	0.000741	0.00313	CcSEcCtD
Methadone—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000738	0.00312	CcSEcCtD
Methadone—Asthenia—Fludarabine—lymphatic system cancer	0.000738	0.00311	CcSEcCtD
Methadone—Rash—Teniposide—lymphatic system cancer	0.000738	0.00311	CcSEcCtD
Methadone—Dermatitis—Teniposide—lymphatic system cancer	0.000737	0.00311	CcSEcCtD
Methadone—Headache—Teniposide—lymphatic system cancer	0.000733	0.00309	CcSEcCtD
Methadone—Pruritus—Fludarabine—lymphatic system cancer	0.000727	0.00307	CcSEcCtD
Methadone—Anorexia—Bleomycin—lymphatic system cancer	0.000719	0.00303	CcSEcCtD
Methadone—Agitation—Vincristine—lymphatic system cancer	0.000707	0.00299	CcSEcCtD
Methadone—Hypotension—Bleomycin—lymphatic system cancer	0.000704	0.00297	CcSEcCtD
Methadone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000704	0.00297	CcSEcCtD
Methadone—Convulsion—Carmustine—lymphatic system cancer	0.000699	0.00295	CcSEcCtD
Methadone—Nausea—Teniposide—lymphatic system cancer	0.000695	0.00293	CcSEcCtD
Methadone—Vertigo—Vincristine—lymphatic system cancer	0.000692	0.00292	CcSEcCtD
Methadone—Anxiety—Carmustine—lymphatic system cancer	0.000684	0.00289	CcSEcCtD
Methadone—Convulsion—Vincristine—lymphatic system cancer	0.000667	0.00282	CcSEcCtD
Methadone—Confusional state—Carmustine—lymphatic system cancer	0.000664	0.0028	CcSEcCtD
Methadone—Oedema—Carmustine—lymphatic system cancer	0.000658	0.00278	CcSEcCtD
Methadone—Decreased appetite—Bleomycin—lymphatic system cancer	0.000655	0.00277	CcSEcCtD
Methadone—Visual disturbance—Methotrexate—lymphatic system cancer	0.000654	0.00276	CcSEcCtD
Methadone—Vomiting—Fludarabine—lymphatic system cancer	0.000654	0.00276	CcSEcCtD
Methadone—Convulsion—Mitoxantrone—lymphatic system cancer	0.000649	0.00274	CcSEcCtD
Methadone—Rash—Fludarabine—lymphatic system cancer	0.000648	0.00274	CcSEcCtD
Methadone—Dermatitis—Fludarabine—lymphatic system cancer	0.000648	0.00273	CcSEcCtD
Methadone—Pain—Bleomycin—lymphatic system cancer	0.000645	0.00272	CcSEcCtD
Methadone—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000644	0.00272	CcSEcCtD
Methadone—Headache—Fludarabine—lymphatic system cancer	0.000644	0.00272	CcSEcCtD
Methadone—Tachycardia—Carmustine—lymphatic system cancer	0.000642	0.00271	CcSEcCtD
Methadone—Anxiety—Mitoxantrone—lymphatic system cancer	0.000636	0.00269	CcSEcCtD
Methadone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000628	0.00265	CcSEcCtD
Methadone—Oedema—Vincristine—lymphatic system cancer	0.000628	0.00265	CcSEcCtD
Methadone—Anorexia—Carmustine—lymphatic system cancer	0.000627	0.00265	CcSEcCtD
Methadone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000621	0.00262	CcSEcCtD
Methadone—Confusional state—Mitoxantrone—lymphatic system cancer	0.000617	0.0026	CcSEcCtD
Methadone—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000615	0.0026	CcSEcCtD
Methadone—Hypotension—Carmustine—lymphatic system cancer	0.000615	0.0026	CcSEcCtD
Methadone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000612	0.00258	CcSEcCtD
Methadone—Oedema—Mitoxantrone—lymphatic system cancer	0.000612	0.00258	CcSEcCtD
Methadone—Nausea—Fludarabine—lymphatic system cancer	0.000611	0.00258	CcSEcCtD
Methadone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000607	0.00256	CcSEcCtD
Methadone—Shock—Mitoxantrone—lymphatic system cancer	0.000602	0.00254	CcSEcCtD
Methadone—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000599	0.00253	CcSEcCtD
Methadone—Urticaria—Bleomycin—lymphatic system cancer	0.000599	0.00253	CcSEcCtD
Methadone—Anorexia—Vincristine—lymphatic system cancer	0.000599	0.00253	CcSEcCtD
Methadone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000597	0.00252	CcSEcCtD
Methadone—Body temperature increased—Bleomycin—lymphatic system cancer	0.000596	0.00252	CcSEcCtD
Methadone—Insomnia—Carmustine—lymphatic system cancer	0.000595	0.00251	CcSEcCtD
Methadone—Irritability—Methotrexate—lymphatic system cancer	0.000592	0.0025	CcSEcCtD
Methadone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000591	0.0025	CcSEcCtD
Methadone—Hypotension—Vincristine—lymphatic system cancer	0.000587	0.00248	CcSEcCtD
Methadone—Somnolence—Carmustine—lymphatic system cancer	0.000585	0.00247	CcSEcCtD
Methadone—Anorexia—Mitoxantrone—lymphatic system cancer	0.000583	0.00246	CcSEcCtD
Methadone—Decreased appetite—Carmustine—lymphatic system cancer	0.000572	0.00242	CcSEcCtD
Methadone—Hypotension—Mitoxantrone—lymphatic system cancer	0.000572	0.00241	CcSEcCtD
Methadone—Insomnia—Vincristine—lymphatic system cancer	0.000568	0.0024	CcSEcCtD
Methadone—Constipation—Carmustine—lymphatic system cancer	0.000563	0.00238	CcSEcCtD
Methadone—Pain—Carmustine—lymphatic system cancer	0.000563	0.00238	CcSEcCtD
Methadone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000555	0.00235	CcSEcCtD
Methadone—Decreased appetite—Vincristine—lymphatic system cancer	0.000546	0.00231	CcSEcCtD
Methadone—Somnolence—Mitoxantrone—lymphatic system cancer	0.000544	0.0023	CcSEcCtD
Methadone—Feeling abnormal—Carmustine—lymphatic system cancer	0.000542	0.00229	CcSEcCtD
Methadone—Asthenia—Bleomycin—lymphatic system cancer	0.000541	0.00228	CcSEcCtD
Methadone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000538	0.00227	CcSEcCtD
Methadone—Pain—Vincristine—lymphatic system cancer	0.000537	0.00227	CcSEcCtD
Methadone—Constipation—Vincristine—lymphatic system cancer	0.000537	0.00227	CcSEcCtD
Methadone—Pruritus—Bleomycin—lymphatic system cancer	0.000533	0.00225	CcSEcCtD
Methadone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000532	0.00225	CcSEcCtD
Methadone—Pain—Mitoxantrone—lymphatic system cancer	0.000523	0.00221	CcSEcCtD
Methadone—Constipation—Mitoxantrone—lymphatic system cancer	0.000523	0.00221	CcSEcCtD
Methadone—Abdominal pain—Carmustine—lymphatic system cancer	0.00052	0.0022	CcSEcCtD
Methadone—Body temperature increased—Carmustine—lymphatic system cancer	0.00052	0.0022	CcSEcCtD
Methadone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000514	0.00217	CcSEcCtD
Methadone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000504	0.00213	CcSEcCtD
Methadone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0005	0.00211	CcSEcCtD
Methadone—Body temperature increased—Vincristine—lymphatic system cancer	0.000497	0.0021	CcSEcCtD
Methadone—Abdominal pain—Vincristine—lymphatic system cancer	0.000497	0.0021	CcSEcCtD
Methadone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000486	0.00205	CcSEcCtD
Methadone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000485	0.00205	CcSEcCtD
Methadone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000484	0.00204	CcSEcCtD
Methadone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000484	0.00204	CcSEcCtD
Methadone—Vomiting—Bleomycin—lymphatic system cancer	0.000479	0.00202	CcSEcCtD
Methadone—Drowsiness—Methotrexate—lymphatic system cancer	0.000478	0.00202	CcSEcCtD
Methadone—Rash—Bleomycin—lymphatic system cancer	0.000475	0.00201	CcSEcCtD
Methadone—Dermatitis—Bleomycin—lymphatic system cancer	0.000475	0.00201	CcSEcCtD
Methadone—Asthenia—Carmustine—lymphatic system cancer	0.000472	0.00199	CcSEcCtD
Methadone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000463	0.00195	CcSEcCtD
Methadone—Sweating—Methotrexate—lymphatic system cancer	0.000458	0.00193	CcSEcCtD
Methadone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000451	0.0019	CcSEcCtD
Methadone—Asthenia—Vincristine—lymphatic system cancer	0.000451	0.0019	CcSEcCtD
Methadone—Diarrhoea—Carmustine—lymphatic system cancer	0.00045	0.0019	CcSEcCtD
Methadone—Nausea—Bleomycin—lymphatic system cancer	0.000448	0.00189	CcSEcCtD
Methadone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000439	0.00185	CcSEcCtD
Methadone—Dizziness—Carmustine—lymphatic system cancer	0.000435	0.00184	CcSEcCtD
Methadone—Diarrhoea—Vincristine—lymphatic system cancer	0.00043	0.00181	CcSEcCtD
Methadone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000419	0.00177	CcSEcCtD
Methadone—Vomiting—Carmustine—lymphatic system cancer	0.000418	0.00177	CcSEcCtD
Methadone—Dizziness—Vincristine—lymphatic system cancer	0.000415	0.00175	CcSEcCtD
Methadone—Rash—Carmustine—lymphatic system cancer	0.000415	0.00175	CcSEcCtD
Methadone—Dermatitis—Carmustine—lymphatic system cancer	0.000415	0.00175	CcSEcCtD
Methadone—Visual impairment—Methotrexate—lymphatic system cancer	0.000413	0.00175	CcSEcCtD
Methadone—Headache—Carmustine—lymphatic system cancer	0.000412	0.00174	CcSEcCtD
Methadone—Vomiting—Vincristine—lymphatic system cancer	0.000399	0.00169	CcSEcCtD
Methadone—Rash—Vincristine—lymphatic system cancer	0.000396	0.00167	CcSEcCtD
Methadone—Dermatitis—Vincristine—lymphatic system cancer	0.000396	0.00167	CcSEcCtD
Methadone—Headache—Vincristine—lymphatic system cancer	0.000394	0.00166	CcSEcCtD
Methadone—Nausea—Carmustine—lymphatic system cancer	0.000391	0.00165	CcSEcCtD
Methadone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000389	0.00164	CcSEcCtD
Methadone—Rash—Mitoxantrone—lymphatic system cancer	0.000386	0.00163	CcSEcCtD
Methadone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000385	0.00163	CcSEcCtD
Methadone—Chills—Methotrexate—lymphatic system cancer	0.000385	0.00163	CcSEcCtD
Methadone—Headache—Mitoxantrone—lymphatic system cancer	0.000383	0.00162	CcSEcCtD
Methadone—Erythema—Methotrexate—lymphatic system cancer	0.000373	0.00158	CcSEcCtD
Methadone—Nausea—Vincristine—lymphatic system cancer	0.000373	0.00158	CcSEcCtD
Methadone—Nausea—Mitoxantrone—lymphatic system cancer	0.000363	0.00153	CcSEcCtD
Methadone—Vertigo—Methotrexate—lymphatic system cancer	0.000336	0.00142	CcSEcCtD
Methadone—Convulsion—Methotrexate—lymphatic system cancer	0.000324	0.00137	CcSEcCtD
Methadone—Confusional state—Methotrexate—lymphatic system cancer	0.000307	0.0013	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000305	0.00129	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000298	0.00126	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000295	0.00124	CcSEcCtD
Methadone—Anorexia—Methotrexate—lymphatic system cancer	0.000291	0.00123	CcSEcCtD
Methadone—Hypotension—Methotrexate—lymphatic system cancer	0.000285	0.0012	CcSEcCtD
Methadone—Insomnia—Methotrexate—lymphatic system cancer	0.000276	0.00116	CcSEcCtD
Methadone—Somnolence—Methotrexate—lymphatic system cancer	0.000271	0.00114	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000265	0.00112	CcSEcCtD
Methadone—Pain—Methotrexate—lymphatic system cancer	0.000261	0.0011	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000251	0.00106	CcSEcCtD
Methadone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000249	0.00105	CcSEcCtD
Methadone—Urticaria—Methotrexate—lymphatic system cancer	0.000242	0.00102	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000241	0.00102	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000241	0.00102	CcSEcCtD
Methadone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000225	0.000948	CcSEcCtD
Methadone—Asthenia—Methotrexate—lymphatic system cancer	0.000219	0.000923	CcSEcCtD
Methadone—Pruritus—Methotrexate—lymphatic system cancer	0.000216	0.000911	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000209	0.000881	CcSEcCtD
Methadone—Dizziness—Methotrexate—lymphatic system cancer	0.000202	0.000851	CcSEcCtD
Methadone—Vomiting—Methotrexate—lymphatic system cancer	0.000194	0.000818	CcSEcCtD
Methadone—Rash—Methotrexate—lymphatic system cancer	0.000192	0.000811	CcSEcCtD
Methadone—Dermatitis—Methotrexate—lymphatic system cancer	0.000192	0.000811	CcSEcCtD
Methadone—Headache—Methotrexate—lymphatic system cancer	0.000191	0.000806	CcSEcCtD
Methadone—Nausea—Methotrexate—lymphatic system cancer	0.000181	0.000764	CcSEcCtD
